Target intelligence / Profile preview

Long intergenic non-protein coding RNA 841 (LINC00841)

Target
LINC00841
Molecular classification
Other (Long non-coding RNA), lncRNA
01

Overview

Long intergenic non-protein coding RNA 841 (LINC00841) is a member of the long non-coding RNA (lncRNA) class, meaning it is a RNA transcript longer than 200 nucleotides that does not encode a protein[1][5]. Its recognized function is regulation of gene expression at the post-transcriptional level, particularly through acting as a competing endogenous RNA (ceRNA). In colorectal cancer (CRC), LINC00841 (also referred to by its alternative symbol linc01184 in some studies due to past nomenclature ambiguities) is upregulated and has been shown to promote cancer cell proliferation and invasion by sponging (sequestering) microRNA-331 (miR-331), which leads to increased expression of HER2 and activation of downstream oncogenic pathways (such as Akt/ERK1/2 signaling)[3]. Evidence currently centers on its oncogenic role in CRC, but there is limited information on its broader physiological functions or its validation as a therapeutic target in other disease contexts. There are no known drugs directly targeting LINC00841 as of the most recent literature, and it is not recognized as a conventional therapeutic target such as a receptor, enzyme, or transporter[1][5][3].

Other names
LINC00841long intergenic non-protein coding RNA 841linc01184
02

Biological functions

Regulation of gene expressionCompetitive endogenous RNA (ceRNA) activityModulation of microRNA function
03

Disease associations

CancerColorectal cancerOncogenic role in CRC

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 841 (LINC00841).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 841 (LINC00841).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call